# EDGAR Filing Document

**Accession Number:** 0002062000
**File Stem:** 0000919574-25-003576
**Filing Date:** 2025-6
**Character Count:** 18597
**Document Hash:** e83aafdf640596613b44d993553a3ef4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000919574-25-003576.hdr.sgml**: 20250612

**ACCESSION NUMBER**: 0000919574-25-003576

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250612

**DATE AS OF CHANGE**: 20250612

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** biote Corp.
- **CENTRAL INDEX KEY:** 0001819253
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 851791125
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92341
- **FILM NUMBER:** 251044579

**BUSINESS ADDRESS:**
- **STREET 1:** 1875 W. WALNUT HILL LN #100
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75038
- **BUSINESS PHONE:** 972-486-9346

**MAIL ADDRESS:**
- **STREET 1:** 1875 W. WALNUT HILL LN #100
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75038

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Haymaker Acquisition Corp. III
- **DATE OF NAME CHANGE:** 20200727
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Roystone Management Holdings LLC
- **CENTRAL INDEX KEY:** 0002062000

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 767 THIRD AVE
- **STREET 2:** 29TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 212-326-6010

**MAIL ADDRESS:**
- **STREET 1:** 767 THIRD AVE
- **STREET 2:** 29TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

## Ex-99

Exhibit A

<u>AGREEMENT</u>

The undersigned agree that this Schedule 13D, dated June 12, 2025, relating to the Class A common stock, par value $0.0001 per share, of biote Corp. shall be filed on behalf of the undersigned.

---

| |
|:---|
| &nbsp;&nbsp; ROYSTONE MANAGEMENT HOLDINGS LLC<br>By: /s/ Laura Roche |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Laura Roche |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: COO/CFO |

---

---

| |
|:---|
| &nbsp;&nbsp; RB MANAGEMENT GP LLC<br>By: /s/ Richard Barrera |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Richard Barrera |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member |

---

---

| |
|:---|
| &nbsp;&nbsp; GUINES LLC<br>By: /s/ Richard Barrera |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Richard Barrera |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member |

---

&nbsp;&nbsp; RICHARD BARRERA<br>By: /s/ Richard Barrera<br>

## Ex-99

Exhibit B

**Schedule of Transactions in Common Stock**

---

| | | | | |
|:---|:---|:---|:---|:---|
| <u>Date of Transaction</u> | <u>Title of Class</u> | <u>Number of Shares Acquired</u> | <u>Number of Shares Disposed</u> | <u>Price Per Share</u> |
| &nbsp;&nbsp;April 16, 2025 | &nbsp;&nbsp;Class A common stock, par value $0.0001 per share | &nbsp;&nbsp;1000 |  | &nbsp;&nbsp;$3.2915 (1) |
| &nbsp;&nbsp;April 17, 2025 | &nbsp;&nbsp;Class A common stock, par value $0.0001 per share | &nbsp;&nbsp;6874 |  | &nbsp;&nbsp;$3.2899 (2) |
| &nbsp;&nbsp;April 21, 2025 | &nbsp;&nbsp;Class A common stock, par value $0.0001 per share | &nbsp;&nbsp;8801 |  | &nbsp;&nbsp;$3.2703 (3) |
| &nbsp;&nbsp;April 30, 2025 | &nbsp;&nbsp;Class A common stock, par value $0.0001 per share | &nbsp;&nbsp;1933 |  | &nbsp;&nbsp;$3.296 (4) |
| &nbsp;&nbsp;May 6, 2025 | &nbsp;&nbsp;Class A common stock, par value $0.0001 per share | &nbsp;&nbsp;436037 |  | &nbsp;&nbsp;$3.2618 (5) |
| &nbsp;&nbsp;May 7, 2025 | &nbsp;&nbsp;Class A common stock, par value $0.0001 per share | &nbsp;&nbsp;11677 |  | &nbsp;&nbsp;$3.3491 (6) |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The price reported in Column 5 is a weighted average price. These shares were bought in multiple transactions
within the range of $3.285 to $3.30. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the
staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate
price within the range set forth in this footnote.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The price reported in Column 5 is a weighted average price. These shares were bought in multiple transactions
within the range of $3.275 to $3.30. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the
staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate
price within the range set forth in this footnote.

&nbsp;&nbsp;&nbsp;&nbsp;(3) The price reported in Column 5 is a weighted average price. These shares were bought in multiple transactions
within the range of $3.25 to $3.28. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the
staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate
price within the range set forth in this footnote.

&nbsp;&nbsp;&nbsp;&nbsp;(4) The price reported in Column 5 is a weighted average price. These shares were bought in multiple transactions
within the range of $3.28 to $3.30. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the
staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate
price within the range set forth in this footnote.

&nbsp;&nbsp;&nbsp;&nbsp;(5) The price reported in Column 5 is a weighted average price. These shares were bought in multiple transactions
within the range of $3.185 to $3.35. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the
staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate
price within the range set forth in this footnote.

&nbsp;&nbsp;&nbsp;&nbsp;(6) The price reported in Column 5 is a weighted average price. These shares
were bought in multiple transactions within the range of $3.34 to $3.35. The Reporting Persons undertake to provide to the Issuer, any
security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number
of shares bought at each separate price within the range set forth in this footnote.

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**biote Corp.**

*(Name of Issuer)*

**Class A common stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**090683103**

*(CUSIP Number)*

**Richard Barrera**<br>c/o Roystone Management Holdings LLC<br>767 Third Avenue, 29th Floor<br>New York NY 10017<br>212-326-6010

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/05/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **090683103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Roystone Management Holdings LLC** | Name of reporting person<br>**Roystone Management Holdings LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4622748.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4622748.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**14.0%** | Percent of class represented by amount in Row (11)<br>**14.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **090683103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**RB Management GP LLC** | Name of reporting person<br>**RB Management GP LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4622748.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4622748.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**14.0%** | Percent of class represented by amount in Row (11)<br>**14.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

| **CUSIP No.** | **090683103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Guines LLC** | Name of reporting person<br>**Guines LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4622748.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4622748.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**14.0%** | Percent of class represented by amount in Row (11)<br>**14.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **090683103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Richard Barrera** | Name of reporting person<br>**Richard Barrera** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4622748.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4622748.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | Aggregate amount beneficially owned by each reporting person<br>**4622748.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**14.0%** | Percent of class represented by amount in Row (11)<br>**14.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A common stock, par value $0.0001 per share

**(b) Name of Issuer:**
biote Corp.

**(c) Address of Issuer's Principal Executive Offices:**
1875 W. Walnut Hill Ln #100, Irving, TX, 75038

**Item 4. Purpose of Transaction**

The Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025.

For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference.

Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D.  However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market transactions or privately negotiated transactions.  The Reporting Persons may also communicate with the Issuer's management, the Issuer's Board and other holders of Common Stock from time to time.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of the date hereof, the Reporting Persons may be deemed to be the beneficial owner of 4,622,748 Common Stock, constituting 14.0% of the Common Stock*.

**(b)**
Each of the Reporting Persons has the sole power to vote or direct the vote of 0 Common Stock; has the shared power to vote or direct the vote of 4,622,748 Common Stock; has the sole power to dispose or direct the disposition of 0 Common Stock; and has the shared power to dispose or direct the disposition of 4,622,748 Common Stock.

*The outstanding Common Stock figure is based on the 33,073,277 Common Stock outstanding as reported in the Issuer's 10-Q filed by the Issuer on May 9, 2025.

**(c)**
The transactions by the Reporting Persons in the Common Stock in the past sixty days are set forth in Exhibit B.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

See Item 4 above.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Roystone Management Holdings LLC

**Signature:** By: /s/ Laura Roche*

**Name/Title:** Laura Roche / COO/CFO

**Date:** 06/12/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** RB Management GP LLC

**Signature:** By: /s/ Richard Barrera*

**Name/Title:** Richard Barrera / Managing Member

**Date:** 06/12/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Guines LLC

**Signature:** By: /s/ Richard Barrera*

**Name/Title:** Richard Barrera / Managing Member

**Date:** 06/12/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Richard Barrera

**Signature:** By: /s/ Richard Barrera*

**Name/Title:** Richard Barrera

**Date:** 06/12/2025